Yomee Lee, Ph.D. - Publications

Affiliations: 
2000 Ohio State University, Columbus, Columbus, OH 
Area:
Physical Education, Ethnic and Racial Studies, Women's Studies

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Lyu M, Lee Y, Kim BS, Kim HJ, Hong R, Shin YU, Cho H, Shin JH. Clinical significance of subclinical atherosclerosis in retinal vein occlusion. Scientific Reports. 11: 11905. PMID 34099806 DOI: 10.1038/s41598-021-91401-1  0.303
2020 Gunasekaran P, Yim MS, Ahn M, Soung NK, Park JE, Kim J, Bang G, Shin SC, Choi J, Kim M, Kim HN, Lee YH, Chung YH, Lee K, EunKyeong Kim E, et al. Development of a Polo-like Kinase-1 Polo-Box Domain Inhibitor as a Tumor Growth Suppressor in Mice Models. Journal of Medicinal Chemistry. PMID 33142063 DOI: 10.1021/acs.jmedchem.0c01451  0.327
2020 Kim JW, Lee YS, Park YS, Kim BH, Lee SY, Yeon JE, Lee CH. Multiparametric MR Index for the Diagnosis of Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease. Scientific Reports. 10: 2671. PMID 32060386 DOI: 10.1038/s41598-020-59601-3  0.306
2020 Edosa TT, Jo YH, Keshavarz M, Park KB, Cho JH, Bae YM, Kim B, Lee YS, Han YS. Atg6 Plays an Important Role in Anti-Microbial Defense Against in the Mealworm, . International Journal of Molecular Sciences. 21. PMID 32059408 DOI: 10.3390/ijms21041232  0.304
2019 Jeong SY, Choi CH, Kim TJ, Lee JW, Kim BG, Bae DS, Lee YY. Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer. Journal of Ovarian Research. 13: 1. PMID 31892329 DOI: 10.1186/s13048-019-0602-5  0.315
2019 Kim SY, Kim SM, Chang H, Kim BW, Lee YS, Chang HS, Park CS. Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea. Frontiers in Endocrinology. 10: 384. PMID 31244783 DOI: 10.3389/fendo.2019.00384  0.354
2018 Shin HR, Bae HS, Kim BS, Yoon HI, Cho YD, Kim WJ, Choi KY, Lee YS, Woo KM, Baek JH, Ryoo HM. PIN1 is a new therapeutic target of craniosynostosis. Human Molecular Genetics. PMID 30007339 DOI: 10.1093/hmg/ddy252  0.307
2018 Kim HY, Kim YH, Yun G, Chang W, Lee YJ, Kim B. Could texture features from preoperative CT image be used for predicting occult peritoneal carcinomatosis in patients with advanced gastric cancer? Plos One. 13: e0194755. PMID 29596522 DOI: 10.1371/journal.pone.0194755  0.304
2018 Hwang J, Soung NK, Han HJ, Lee Y, Choi TW, Mun J, Cha-Molstad H, Lee KH, Kim HJ, Lee HG, Hong JT, Ahn JS, Kwon YT, Kim BY. A novel tubulin inhibitor STK899704 induces tumor regression in DMBA/TPA induced skin carcinogenesis model. Experimental Dermatology. PMID 29392819 DOI: 10.1111/Exd.13506  0.333
2018 Lee YS, Kim SM, Kim BW, Chang HJ, Kim SY, Park CS, Park KC, Chang HS. Anti-cancer Effects of HNHA and Lenvatinib by the Suppression of EMT-Mediated Drug Resistance in Cancer Stem Cells. Neoplasia (New York, N.Y.). 20: 197-206. PMID 29331886 DOI: 10.1016/j.neo.2017.12.003  0.364
2017 Yoo YD, Lee DH, Cha-Molstad H, Kim H, Mun SR, Ji C, Park SH, Sung KS, Choi SA, Hwang J, Park DM, Kim SK, Park KJ, Kang SH, Oh SC, ... ... Lee YJ, et al. Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibition. Embo Reports. 18: 1671. PMID 28864661 DOI: 10.15252/Embr.201744761  0.309
2017 Jang HI, Kim SE, Kim TJ, Lee YY, Choi CH, Lee JW, Kim BG, Bae DS. Catamenial hemoptysis accompanied by subcutaneous endometriosis treated with combination therapy. Obstetrics & Gynecology Science. 60: 236-239. PMID 28344969 DOI: 10.5468/ogs.2017.60.2.236  0.303
2017 Jang HI, Lim SH, Lee YY, Kim TJ, Choi CH, Lee JW, Kim BG, Bae DS. Perioperative administration of propranolol to women undergoing ovarian cancer surgery: A pilot study. Obstetrics & Gynecology Science. 60: 170-177. PMID 28344958 DOI: 10.5468/ogs.2017.60.2.170  0.314
2017 Park KC, Kim SM, Jeon JY, Kim BW, Kim HK, Chang HJ, Lee YS, Kim SY, Choi SH, Park CS, Chang HS. Synergistic activity of N-hydroxy-7-(2-naphthylthio) heptanomide and sorafenib against cancer stem cells, anaplastic thyroid cancer. Neoplasia (New York, N.Y.). 19: 145-153. PMID 28142087 DOI: 10.1016/j.neo.2016.12.005  0.363
2016 Yoo YD, Lee DH, Cha-Molstad H, Kim H, Mun SR, Ji C, Park SH, Sung KS, Choi SA, Hwang J, Park DM, Kim SK, Park KJ, Kang SH, Oh SC, ... ... Lee YJ, et al. Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibition. Embo Reports. PMID 27993939 DOI: 10.15252/Embr.201642360  0.324
2016 Lee YY, Jeon HK, Lee J, Hong JE, DO IG, Choi CH, Kim TJ, Kim BG, Bae DS, Kim YC, Lee JW. Dynamin 2 Inhibitors as Novel Therapeutic Agents Against Cervical Cancer Cells. Anticancer Research. 36: 6381-6388. PMID 27919959 DOI: 10.21873/Anticanres.11235  0.323
2016 Paik ES, Shim M, Choi HJ, Lee YY, Kim TJ, Choi CH, Lee JW, Kim BG, Bae DS. Preoperative multiplication of neutrophil and monocyte counts as a prognostic factor in epithelial ovarian cancer. Cancer Biomarkers : Section a of Disease Markers. PMID 27802193 DOI: 10.3233/CBM-160658  0.321
Show low-probability matches.